- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 317/18 - SulfonesSulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
Patent holdings for IPC class C07C 317/18
Total number of patents in this class: 141
10-year publication summary
|
10
|
14
|
13
|
9
|
11
|
7
|
7
|
6
|
5
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alkermes Pharma Ireland Limited | 254 |
16 |
| PRC-DeSoto International, Inc. | 570 |
8 |
| BASF SE | 21308 |
5 |
| Duke University | 3182 |
5 |
| The University of North Carolina at Chapel Hill | 2104 |
5 |
| ProLynx LLC | 60 |
4 |
| The University of British Columbia | 1546 |
4 |
| Boehringer Ingelheim International GmbH | 4493 |
3 |
| Sumitomo Chemical Company, Limited | 8968 |
3 |
| Kappa Bioscience AS | 42 |
3 |
| Provincial Health Services Authority | 195 |
3 |
| Translate bio, Inc. | 415 |
3 |
| Bristol-myers Squibb Company | 4751 |
2 |
| Merck Patent GmbH | 5729 |
2 |
| Board of Regents, The University of Texas System | 6117 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2304 |
2 |
| Central Glass Company, Limited | 1295 |
2 |
| Dalian University of Technology | 1594 |
2 |
| Reviva Pharmaceuticals, Inc. | 50 |
2 |
| Sanford Burnham Prebys Medical Discovery Institute | 307 |
2 |
| Other owners | 63 |